Cargando…

Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls

Background: Up to 53% of individuals who had mild COVID-19 experience symptoms for >3-month following infection (Long-CoV). Dyspnea is reported in 60% of Long-CoV cases and may be secondary to impaired exercise capacity (VO(2peak)) as a result of pulmonary, pulmonary vascular, or cardiac insult....

Descripción completa

Detalles Bibliográficos
Autores principales: Beaudry, Rhys I., Brotto, Andrew R., Varughese, Rhea A., de Waal, Stephanie, Fuhr, Desi P., Damant, Ronald W., Ferrara, Giovanni, Lam, Grace Y., Smith, Maeve P., Stickland, Michael K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297912/
https://www.ncbi.nlm.nih.gov/pubmed/35874528
http://dx.doi.org/10.3389/fphys.2022.917886
_version_ 1784750579792216064
author Beaudry, Rhys I.
Brotto, Andrew R.
Varughese, Rhea A.
de Waal, Stephanie
Fuhr, Desi P.
Damant, Ronald W.
Ferrara, Giovanni
Lam, Grace Y.
Smith, Maeve P.
Stickland, Michael K.
author_facet Beaudry, Rhys I.
Brotto, Andrew R.
Varughese, Rhea A.
de Waal, Stephanie
Fuhr, Desi P.
Damant, Ronald W.
Ferrara, Giovanni
Lam, Grace Y.
Smith, Maeve P.
Stickland, Michael K.
author_sort Beaudry, Rhys I.
collection PubMed
description Background: Up to 53% of individuals who had mild COVID-19 experience symptoms for >3-month following infection (Long-CoV). Dyspnea is reported in 60% of Long-CoV cases and may be secondary to impaired exercise capacity (VO(2peak)) as a result of pulmonary, pulmonary vascular, or cardiac insult. This study examined whether cardiopulmonary mechanisms could explain exertional dyspnea in Long-CoV. Methods: A cross-sectional study of participants with Long-CoV (n = 28, age 40 ± 11 years, 214 ± 85 days post-infection) and age- sex- and body mass index-matched COVID-19 naïve controls (Con, n = 24, age 41 ± 12 years) and participants fully recovered from COVID-19 (ns-CoV, n = 14, age 37 ± 9 years, 198 ± 89 days post-infection) was conducted. Participants self-reported symptoms and baseline dyspnea (modified Medical Research Council, mMRC, dyspnea grade), then underwent a comprehensive pulmonary function test, cardiopulmonary exercise test, exercise pulmonary diffusing capacity measurement, and rest and exercise echocardiography. Results: VO(2peak), pulmonary function and cardiac/pulmonary vascular parameters were not impaired in Long- or ns-CoV compared to normative values (VO(2peak): 106 ± 25 and 107 ± 25%(predicted), respectively) and cardiopulmonary responses to exercise were otherwise normal. When Long-CoV were stratified by clinical dyspnea severity (mMRC = 0 vs mMRC≥1), there were no between-group differences in VO(2peak). During submaximal exercise, dyspnea and ventilation were increased in the mMRC≥1 group, despite normal operating lung volumes, arterial saturation, diffusing capacity and indicators of pulmonary vascular pressures. Interpretation: Persistent dyspnea after COVID-19 was not associated with overt cardiopulmonary impairment or exercise intolerance. Interventions focusing on dyspnea management may be appropriate for Long-CoV patients who report dyspnea without cardiopulmonary impairment.
format Online
Article
Text
id pubmed-9297912
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92979122022-07-21 Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls Beaudry, Rhys I. Brotto, Andrew R. Varughese, Rhea A. de Waal, Stephanie Fuhr, Desi P. Damant, Ronald W. Ferrara, Giovanni Lam, Grace Y. Smith, Maeve P. Stickland, Michael K. Front Physiol Physiology Background: Up to 53% of individuals who had mild COVID-19 experience symptoms for >3-month following infection (Long-CoV). Dyspnea is reported in 60% of Long-CoV cases and may be secondary to impaired exercise capacity (VO(2peak)) as a result of pulmonary, pulmonary vascular, or cardiac insult. This study examined whether cardiopulmonary mechanisms could explain exertional dyspnea in Long-CoV. Methods: A cross-sectional study of participants with Long-CoV (n = 28, age 40 ± 11 years, 214 ± 85 days post-infection) and age- sex- and body mass index-matched COVID-19 naïve controls (Con, n = 24, age 41 ± 12 years) and participants fully recovered from COVID-19 (ns-CoV, n = 14, age 37 ± 9 years, 198 ± 89 days post-infection) was conducted. Participants self-reported symptoms and baseline dyspnea (modified Medical Research Council, mMRC, dyspnea grade), then underwent a comprehensive pulmonary function test, cardiopulmonary exercise test, exercise pulmonary diffusing capacity measurement, and rest and exercise echocardiography. Results: VO(2peak), pulmonary function and cardiac/pulmonary vascular parameters were not impaired in Long- or ns-CoV compared to normative values (VO(2peak): 106 ± 25 and 107 ± 25%(predicted), respectively) and cardiopulmonary responses to exercise were otherwise normal. When Long-CoV were stratified by clinical dyspnea severity (mMRC = 0 vs mMRC≥1), there were no between-group differences in VO(2peak). During submaximal exercise, dyspnea and ventilation were increased in the mMRC≥1 group, despite normal operating lung volumes, arterial saturation, diffusing capacity and indicators of pulmonary vascular pressures. Interpretation: Persistent dyspnea after COVID-19 was not associated with overt cardiopulmonary impairment or exercise intolerance. Interventions focusing on dyspnea management may be appropriate for Long-CoV patients who report dyspnea without cardiopulmonary impairment. Frontiers Media S.A. 2022-07-06 /pmc/articles/PMC9297912/ /pubmed/35874528 http://dx.doi.org/10.3389/fphys.2022.917886 Text en Copyright © 2022 Beaudry, Brotto, Varughese, de Waal, Fuhr, Damant, Ferrara, Lam, Smith and Stickland. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Beaudry, Rhys I.
Brotto, Andrew R.
Varughese, Rhea A.
de Waal, Stephanie
Fuhr, Desi P.
Damant, Ronald W.
Ferrara, Giovanni
Lam, Grace Y.
Smith, Maeve P.
Stickland, Michael K.
Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls
title Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls
title_full Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls
title_fullStr Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls
title_full_unstemmed Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls
title_short Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls
title_sort persistent dyspnea after covid-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic covid-19, non-dyspneic covid-19 and controls
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297912/
https://www.ncbi.nlm.nih.gov/pubmed/35874528
http://dx.doi.org/10.3389/fphys.2022.917886
work_keys_str_mv AT beaudryrhysi persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT brottoandrewr persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT varugheserheaa persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT dewaalstephanie persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT fuhrdesip persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT damantronaldw persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT ferraragiovanni persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT lamgracey persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT smithmaevep persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols
AT sticklandmichaelk persistentdyspneaaftercovid19isnotrelatedtocardiopulmonaryimpairmentacrosssectionalstudyofpersistentlydyspneiccovid19nondyspneiccovid19andcontrols